Thumbs Down From FDA Panel on Plastic Meniscus Replacement

(MedPage Today) -- An FDA advisory committee voted 6-2, with one absention, that a novel, synthetic knee meniscus replacement's benefits do not outweigh its risks, and thus is not suitable for marketing. Members of the Orthopaedic and Rehabilitation...
Source: MedPage Today Rheumatology - Category: Rheumatology Source Type: news